In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA) (Q73899272)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9378534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9378534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

antineoplastic resistance

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9378534

25 November 2024

R Larsson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9378534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Nygren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9378534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K. Csóka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9378534

25 November 2024

B. Tholander

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9378534

25 November 2024

E. Gerdin

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9378534

25 November 2024

M. de la Torre

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9378534

25 November 2024

language of work or name

English

0 references

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9378534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

17 September 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9378534

full work available at URL

25 November 2024

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/%28SICI%291097-0215%2819970917%2972%3A6%3C1008%3A%3AAID-IJC15%3E3.0.CO%3B2-0

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9378534

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

25 November 2024

1 reference

Crossref

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

25 November 2024

1 reference

Crossref

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

International Journal of Cancer

25 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9378534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9378534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9378534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1008-1012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9378534%20AND%20SRC:MED&resulttype=core&format=json

Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).

7 November 2019

cites work

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

Selective sensitivity of solid tumors to suramin in primary cultures of tumor cells from patients

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

Platinum-Taxol non-cross resistance in epithelial ovarian cancer

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia.

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA).

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

The subrenal capsule assay in selecting chemotherapy for ovarian cancer: a prospective randomized trial

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

Cell biological markers of drug resistance in ovarian carcinoma.

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

25 November 2024

1926

Von Hoff

1983

1 reference

Crossref

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer

25 November 2024

1 reference

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970917)72:6%3C1008::AID-IJC15%3E3.0.CO;2-0

25 November 2024

Identifiers

10.1002/(SICI)1097-0215(19970917)72:6<1008::AID-IJC15>3.0.CO;2-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9378534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9378534%20AND%20SRC:MED&resulttype=core&format=json